Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Expression of multiple myeloma associated markers in bone marrow spicules using a novel immunohistochemical technique.

Santra M, Shaughnessy JD Jr, Bellamy WT.

Biotech Histochem. 2011 Apr;86(2):119-23. doi: 10.3109/10520290903565978. Epub 2010 May 3.

3.
4.

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.

Bayer-Garner IB, Sanderson RD, Dhodapkar MV, Owens RB, Wilson CS.

Mod Pathol. 2001 Oct;14(10):1052-8.

6.

Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.

Liu D, Lin P, Hu Y, Zhou Y, Tang G, Powers L, Medeiros LJ, Jorgensen JL, Wang SA.

J Clin Pathol. 2012 Sep;65(9):823-9. doi: 10.1136/jclinpath-2012-200881. Epub 2012 Jun 8.

PMID:
22685235
8.

Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.

Hwang K, Park CJ, Jang S, Chi HS, Huh JR, Lee JH, Suh C, Lee KH.

Histopathology. 2013 Apr;62(5):764-70. doi: 10.1111/his.12079. Epub 2013 Mar 7.

PMID:
23470050
9.

Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma.

Mansoor A, Akhter A, Pournazari P, Mahe E, Shariff S, Farooq F, Elyamany G, Shahbani-Rad MT, Rashid-Kolvear F.

Appl Immunohistochem Mol Morphol. 2015 May-Jun;23(5):327-33. doi: 10.1097/PAI.0000000000000089.

PMID:
25265432
10.

Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.

Ioannou MG, Stathakis E, Lazaris AC, Papathomas T, Tsiambas E, Koukoulis GK.

Pathol Oncol Res. 2009 Mar;15(1):25-9. doi: 10.1007/s12253-008-9069-1. Epub 2008 Jun 14.

PMID:
18553158
11.

Reactive histiocytosis: a diagnostic dilemma in multiple myeloma.

Singh Sachdeva MU, Das R, Ahluwalia J, Varma N.

Indian J Pathol Microbiol. 2010 Jul-Sep;53(3):577-8. doi: 10.4103/0377-4929.68253. No abstract available.

12.

Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.

Al-Quran SZ, Yang L, Magill JM, Braylan RC, Douglas-Nikitin VK.

Hum Pathol. 2007 Dec;38(12):1779-87. Epub 2007 Aug 21.

13.

CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.

Chilosi M, Adami F, Lestani M, Montagna L, Cimarosto L, Semenzato G, Pizzolo G, Menestrina F.

Mod Pathol. 1999 Dec;12(12):1101-6.

PMID:
10619261
15.

[Detection of multiple myeloma cells using multicolor immunofluorescence and flow cytometry].

Tousková M, Maisnar V, Krejsek J, Kopecký O.

Vnitr Lek. 1999 Dec;45(12):708-12. Czech.

PMID:
10951845
16.

Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.

Matsue K, Matsue Y, Kumata K, Usui Y, Suehara Y, Fukumoto K, Fujisawa M, Narita K, Takeuchi M.

Hematol Oncol. 2016 May 3. doi: 10.1002/hon.2300. [Epub ahead of print]

PMID:
27140172
17.

Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.

García-Sanz R, González M, Orfão A, Moro MJ, Hernández JM, Borrego D, Carnero M, Casanova F, Bárez A, Jiménez R, Portero JA, San Miguel JF.

Br J Haematol. 1996 Apr;93(1):81-8.

PMID:
8611480
18.

Characterization of bone marrow stromal cells from multiple myeloma.

Gregoretti MG, Gottardi D, Ghia P, Bergui L, Merico F, Marchisio PC, Caligaris-Cappio F.

Leuk Res. 1994 Sep;18(9):675-82.

PMID:
7934143
19.

Plasma cell myeloma marrow diagnosis including morphologic and phenotypic features.

Grogan TM.

Semin Diagn Pathol. 2003 Aug;20(3):211-25. Review.

PMID:
14552432
20.

Detection of bone marrow metastases of neuroblastoma with immunohistochemical staining of CD56, chromogranin A, and synaptophysin.

Park SJ, Park CJ, Kim S, Jang S, Chi HS, Kim MJ, Im HJ, Seo JJ.

Appl Immunohistochem Mol Morphol. 2010 Jul;18(4):348-52. doi: 10.1097/PAI.0b013e3181d2ed4c.

PMID:
20216406

Supplemental Content

Support Center